Last week, the U.S. House Committee on Energy and Commerce Subcommittee on Health held a hearing entitled, “Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care.
The committee heard testimony from Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure, as well as from several advocacy organizations — including groups representing hospitals, pharmacy benefit managers, patients and employers. Policymakers are considering measures that take aim at high health costs and increasing consolidation among hospitals and physician practices, and insurers with pharmacy benefit managers (PBMs). Of the 17 measures, some are bills that have been introduced in the House of Representatives and others are discussion drafts.
The subcommittee questioned CMS Administrator Brooks-LaSure regarding policies on Alzheimer’s drug coverage and hospital price-transparency rules being implemented by the agency. Other topics that were raised at the hearing include surprise billing, physician-owned hospitals and site neutral payment policies.
The American College of Radiology® (ACR®) will continue to monitor these congressional proposals impacting healthcare costs and transparency. For additional information, contact Ashley Walton, ACR Director of Government Affairs.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more